
FDA refuses to review Moderna’s application for mRNA flu vaccine, company says
CNN
The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu vaccine, the company said Tuesday, in another setback for the technology that’s been a target of some Trump administration health officials.
More Related News

Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of treatments to fire up their immune systems. The only difference was that half the group got their medications earlier in the day, before 3 p.m., and the other half got them later.












